294 related articles for article (PubMed ID: 25471810)
21. Effect of changing the lipid component of home parenteral nutrition in adults.
Osowska S; Kunecki M; Sobocki J; Tokarczyk J; Majewska K; Omidi M; Radkowski M; Fisk HL; Calder PC
Clin Nutr; 2019 Jun; 38(3):1355-1361. PubMed ID: 29907355
[TBL] [Abstract][Full Text] [Related]
22. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease.
de Meijer VE; Gura KM; Meisel JA; Le HD; Puder M
Arch Surg; 2010 Jun; 145(6):547-51. PubMed ID: 20566974
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of an olive oil-based intravenous fat emulsion in adult patients on home parenteral nutrition.
Reimund JM; Rahmi G; Escalin G; Pinna G; Finck G; Muller CD; Duclos B; Baumann R
Aliment Pharmacol Ther; 2005 Feb; 21(4):445-54. PubMed ID: 15709996
[TBL] [Abstract][Full Text] [Related]
24. Emergence of Mixed-Oil Fat Emulsions for Use in Parenteral Nutrition.
Mundi MS; Martindale RG; Hurt RT
JPEN J Parenter Enteral Nutr; 2017 Nov; 41(1_suppl):3S-13S. PubMed ID: 29161196
[TBL] [Abstract][Full Text] [Related]
25. Intravenous lipid emulsions and liver function in adult chronic intestinal failure patients: Results after 5 y of home parenteral nutrition.
Klek S; Szczepanek K; Scislo L; Walewska E; Pietka M; Pisarska M; Pedziwiatr M
Nutrition; 2021 Feb; 82():111029. PubMed ID: 33221116
[TBL] [Abstract][Full Text] [Related]
26. Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease.
Koletzko B; Goulet O
Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):321-6. PubMed ID: 20393276
[TBL] [Abstract][Full Text] [Related]
27. Intravenous lipid emulsions and liver function in adult chronic intestinal failure patients: results from a randomized clinical trial.
Klek S; Szczepanek K; Scislo L; Walewska E; Pietka M; Pisarska M; Pedziwiatr M
Nutrition; 2018 Nov; 55-56():45-50. PubMed ID: 29960156
[TBL] [Abstract][Full Text] [Related]
28. No Clinical or Biochemical Evidence for Essential Fatty Acid Deficiency in Home Patients Who Depend on Long-Term Mixed Olive Oil- and Soybean Oil-Based Parenteral Nutrition.
Olthof ED; Roelofs HM; Fisk HL; Calder PC; Wanten GJ
JPEN J Parenter Enteral Nutr; 2016 Sep; 40(7):982-8. PubMed ID: 25888677
[TBL] [Abstract][Full Text] [Related]
29. Erythrocyte fatty acid membrane composition in children on long-term parenteral nutrition enriched with ω-3 fatty acids.
Goulet O; Lamazière A; Abi Nader E; Talbotec C; Wolf C; Lambe C
Am J Clin Nutr; 2022 Feb; 115(2):422-431. PubMed ID: 34582547
[TBL] [Abstract][Full Text] [Related]
30. Case Report: Transitioning to a Mixed-Oil Intravenous Lipid Emulsion in an Adult Patient Receiving Home Parenteral Nutrition.
Bathgate JR; Matarese L; Ziegler J; Touger-Decker R
Nutr Clin Pract; 2020 Oct; 35(5):871-884. PubMed ID: 31478264
[TBL] [Abstract][Full Text] [Related]
31. Prevention of parenteral nutrition-associated liver disease: lipid minimization.
Cober MP; Teitelbaum DH
Curr Opin Organ Transplant; 2010 Jun; 15(3):330-3. PubMed ID: 20386446
[TBL] [Abstract][Full Text] [Related]
32. Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions.
Nandivada P; Carlson SJ; Chang MI; Cowan E; Gura KM; Puder M
Adv Nutr; 2013 Nov; 4(6):711-7. PubMed ID: 24228202
[TBL] [Abstract][Full Text] [Related]
33. Lipids and liver dysfunction in patients receiving parenteral nutrition.
Gabe SM
Curr Opin Clin Nutr Metab Care; 2013 Mar; 16(2):150-5. PubMed ID: 23340009
[TBL] [Abstract][Full Text] [Related]
34. Short-term infusion of a fish oil-based lipid emulsion modulates fatty acid status, but not immune function or (anti)oxidant balance: a randomized cross-over study.
Versleijen MW; Roelofs HM; Rombouts C; Hermans PW; Noakes PS; Calder PC; Wanten GJ
Eur J Clin Invest; 2012 Mar; 42(3):290-302. PubMed ID: 21880037
[TBL] [Abstract][Full Text] [Related]
35. Lipid peroxidation and antioxidant status in adults receiving lipid-based home parenteral nutrition.
Pironi L; Ruggeri E; Zolezzi C; Savarino L; Incasa E; Belluzzi A; Munarini A; Piazzi S; Tolomelli M; Pizzoferrato A; Miglioli M
Am J Clin Nutr; 1998 Oct; 68(4):888-93. PubMed ID: 9771867
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms for the effects of fish oil lipid emulsions in the management of parenteral nutrition-associated liver disease.
Nandivada P; Cowan E; Carlson SJ; Chang M; Gura KM; Puder M
Prostaglandins Leukot Essent Fatty Acids; 2013 Sep; 89(4):153-8. PubMed ID: 23602846
[TBL] [Abstract][Full Text] [Related]
37. Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans.
Mayer K; Meyer S; Reinholz-Muhly M; Maus U; Merfels M; Lohmeyer J; Grimminger F; Seeger W
J Immunol; 2003 Nov; 171(9):4837-43. PubMed ID: 14568963
[TBL] [Abstract][Full Text] [Related]
38. Dispelling myths about intravenous fish oil-based lipid emulsions: a clinical perspective.
ApSimon M
Curr Opin Clin Nutr Metab Care; 2018 Mar; 21(2):97-103. PubMed ID: 29256925
[TBL] [Abstract][Full Text] [Related]
39. Intestinal failure-associated liver disease and the use of fish oil-based lipid emulsions.
Goulet OJ
World Rev Nutr Diet; 2015; 112():90-114. PubMed ID: 25471806
[TBL] [Abstract][Full Text] [Related]
40. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition.
Goulet O; Antébi H; Wolf C; Talbotec C; Alcindor LG; Corriol O; Lamor M; Colomb-Jung V
JPEN J Parenter Enteral Nutr; 2010; 34(5):485-95. PubMed ID: 20852176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
